Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for ureteral stent-related pain and LUTS
NCT02095665Phase 4Completed
- Sponsor
- Nova Scotia Health
- Start
- Jan 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in ureteral stent-related symptoms (USRS), sponsored by Nova Scotia Health. Started Jan 2014; status: completed.
02
Drugs
mirabegron
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT02095665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095665.